Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BR101801
i
Other names:
BR101801, BR 101801, BR2002
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Boryung Group
Drug class:
PI3Kδ inhibitor, PI3Kγ inhibitor, DNA PK inhibitor
Related drugs:
‹
copanlisib (30)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
AZD8835 (1)
IPI-549 (6)
CZC24832 (1)
CC-115 (3)
AZD7648 (2)
M3814 (2)
NU7441 (1)
copanlisib (30)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
AZD8835 (1)
IPI-549 (6)
CZC24832 (1)
CC-115 (3)
AZD7648 (2)
M3814 (2)
NU7441 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
MYC expression + MCL1 expression
Diffuse Large B Cell Lymphoma
MYC expression + MCL1 expression
Diffuse Large B Cell Lymphoma
venetoclax + BR101801
Sensitive: D – Preclinical
venetoclax + BR101801
Sensitive
:
D
venetoclax + BR101801
Sensitive: D – Preclinical
venetoclax + BR101801
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login